Login to Your Account



Intercell Shares Rise on CHMP Positive Opinion for Ixiaro

By Cormac Sheridan


Wednesday, December 17, 2008
Shares in Intercell AG rose by more than 8.5 percent Monday on news that the company's lead product, a vaccine against Japanese Encephalitis virus (JEV), received a positive opinion from the Committee on Human Medicinal Products, of the European Medicines Agency. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription